Literature DB >> 10194472

Heteropolymerization of S, I, and Z alpha1-antitrypsin and liver cirrhosis.

R Mahadeva1, W S Chang, T R Dafforn, D J Oakley, R C Foreman, J Calvin, D G Wight, D A Lomas.   

Abstract

The association between Z alpha1-antitrypsin deficiency and juvenile cirrhosis is well-recognized, and there is now convincing evidence that the hepatic inclusions are the result of entangled polymers of mutant Z alpha1-antitrypsin. Four percent of the northern European Caucasian population are heterozygotes for the Z variant, but even more common is S alpha1-antitrypsin, which is found in up to 28% of southern Europeans. The S variant is known to have an increased susceptibility to polymerization, although this is marginal compared with the more conformationally unstable Z variant. There has been speculation that the two may interact to produce cirrhosis, but this has never been demonstrated experimentally. This hypothesis was raised again by the observation reported here of a mixed heterozygote for Z alpha1-antitrypsin and another conformationally unstable variant (I alpha1-antitrypsin; 39Arg-->Cys) identified in a 34-year-old man with cirrhosis related to alpha1-antitrypsin deficiency. The conformational stability of the I variant has been characterized, and we have used fluorescence resonance energy transfer to demonstrate the formation of heteropolymers between S and Z alpha1-antitrypsin. Taken together, these results indicate that not only may mixed variants form heteropolymers, but that this can causally lead to the development of cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10194472      PMCID: PMC408255          DOI: 10.1172/JCI4874

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  41 in total

1.  Serpin alpha 1proteinase inhibitor probed by intrinsic tryptophan fluorescence spectroscopy.

Authors:  H Koloczek; A Banbula; G S Salvesen; J Potempa
Journal:  Protein Sci       Date:  1996-11       Impact factor: 6.725

2.  Inhibitory conformation of the reactive loop of alpha 1-antitrypsin.

Authors:  P R Elliott; D A Lomas; R W Carrell; J P Abrahams
Journal:  Nat Struct Biol       Date:  1996-08

3.  Structural explanation for the deficiency of S alpha 1-antitrypsin.

Authors:  P R Elliott; P E Stein; D Bilton; R W Carrell; D A Lomas
Journal:  Nat Struct Biol       Date:  1996-11

Review 4.  Wild-type alpha 1-antitrypsin is in the canonical inhibitory conformation.

Authors:  P R Elliott; J P Abrahams; D A Lomas
Journal:  J Mol Biol       Date:  1998-01-23       Impact factor: 5.469

5.  Studies in alpha 1-antitrypsin deficiency.

Authors:  S Eriksson
Journal:  Acta Med Scand Suppl       Date:  1965

6.  Cirrhosis associated with partial deficiency of alpha-1 antitrypsin in an adult.

Authors:  J L Campra; J R Craig; R L Peters; T B Reynolds
Journal:  Ann Intern Med       Date:  1973-02       Impact factor: 25.391

7.  Serum Pi types in some European, American, Asian and African populations.

Authors:  M K Fagerhol; O W Tenfjord
Journal:  Acta Pathol Microbiol Scand       Date:  1968

8.  Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants.

Authors:  T Sveger
Journal:  N Engl J Med       Date:  1976-06-10       Impact factor: 91.245

9.  Heterozygous alpha 1-antitrypsin deficiency and cirrhosis in adults, a fortuitous association.

Authors:  T Morin; J P Martin; G Feldmann; B Rueff; J P Benhamou; C Ropartz
Journal:  Lancet       Date:  1975-02-01       Impact factor: 79.321

10.  Study of familial alpha-1-proteinase inhibitor deficiency including a rare proteinase inhibitor phenotype (IZ). I. Alpha-1-phenotyping and clinical investigations.

Authors:  X Baur; K Bencze
Journal:  Respiration       Date:  1987       Impact factor: 3.580

View more
  45 in total

Review 1.  Alpha-1 antitrypsin deficiency.

Authors:  R A Primhak; M S Tanner
Journal:  Arch Dis Child       Date:  2001-07       Impact factor: 3.791

Review 2.  Alpha1-antitrypsin polymerization and the serpinopathies: pathobiology and prospects for therapy.

Authors:  David A Lomas; Ravi Mahadeva
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

3.  Simultaneous phenotyping and quantification of α-1-antitrypsin by liquid chromatography-tandem mass spectrometry.

Authors:  Yuhong Chen; Melissa R Snyder; Yi Zhu; Linda J Tostrud; Linda M Benson; Jerry A Katzmann; H Robert Bergen
Journal:  Clin Chem       Date:  2011-06-02       Impact factor: 8.327

4.  Dominant-negative SERPING1 variants cause intracellular retention of C1 inhibitor in hereditary angioedema.

Authors:  Didde Haslund; Laura Barrett Ryø; Sara Seidelin Majidi; Iben Rose; Kristian Alsbjerg Skipper; Tue Fryland; Anja Bille Bohn; Claus Koch; Martin K Thomsen; Yaseelan Palarasah; Thomas J Corydon; Anette Bygum; Lene N Nejsum; Jacob Giehm Mikkelsen
Journal:  J Clin Invest       Date:  2018-12-10       Impact factor: 14.808

5.  Outcome of PiSS and PiSZ alpha-1-antitrypsin deficiency presenting with liver involvement.

Authors:  Nedim Hadzic; Ruggiero Francavilla; Susan M Chambers; Stefania Castellaneta; Bernard Portmann; Giorgina Mieli-Vergani
Journal:  Eur J Pediatr       Date:  2005-02-15       Impact factor: 3.183

Review 6.  Protein misfolding and the serpinopathies.

Authors:  Didier Belorgey; Peter Hägglöf; Susanna Karlsson-Li; David A Lomas
Journal:  Prion       Date:  2007-01-06       Impact factor: 3.931

7.  Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency.

Authors:  Irina Petrache; Joud Hajjar; Michael Campos
Journal:  Biologics       Date:  2009-07-13

8.  Oxidized {alpha}1-antitrypsin stimulates the release of monocyte chemotactic protein-1 from lung epithelial cells: potential role in emphysema.

Authors:  Zhenjun Li; Sam Alam; Jicun Wang; Caroline S Sandstrom; Sabina Janciauskiene; Ravi Mahadeva
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-06-12       Impact factor: 5.464

9.  Alpha-1-antitrypsin phenotypes in adult liver disease patients.

Authors:  Aleksandra Topic; Tamara Alempijevic; Aleksandra Sokic Milutinovic; Nada Kovacevic
Journal:  Ups J Med Sci       Date:  2009       Impact factor: 2.384

10.  Crystallographic and cellular characterisation of two mechanisms stabilising the native fold of alpha1-antitrypsin: implications for disease and drug design.

Authors:  Bibek Gooptu; Elena Miranda; Irene Nobeli; Meera Mallya; Andrew Purkiss; Sarah C Leigh Brown; Charlotte Summers; Russell L Phillips; David A Lomas; Tracey E Barrett
Journal:  J Mol Biol       Date:  2009-02-14       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.